Polyomavirus and related diseases
Polyomavirus and related diseases is a research topic within Oncology. Science Explorer counts 23k research works in it since 1950. 17.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the association between polyomaviruses, particularly Merkel cell polyomavirus and JC virus, with the development of malignancies such as Merkel cell carcinoma and the manifestation of progressive multifocal leukoencephalopathy in immunocompromised individuals. It also explores the impact of immunosuppressive therapies, viral replication in renal transplant recipients, and the potential role of viral oncoproteins in promoting tumorigenesis.
- Polyomavirus
- Merkel Cell Carcinoma
- Progressive Multifocal Leukoencephalopathy
- Natalizumab
- Renal Transplantation
- T antigen mutations
- Viral Oncoproteins
- Immunosuppression
- Viral Nephropathy
- JC Virus
- Research works
- 23k fractional, since 1950
- In the world top 10%
- 4.1k per year above
- Top-10% rate
- 17.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +15% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Polyomavirus and related diseases research?
By volume, the United States and China publish the most (1.1k and 280 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.1k works
- 2 China 280 works
- 3 Japan 169 works
- 4 Italy 156 works
- 5 Germany 132 works
- 6 India 131 works
- 7 France 128 works
- 8 United Kingdom 107 works
- 9 Spain 96 works
- 10 Türkiye 68 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Polyomavirus and related diseases research?
By volume in 2022–2025, University of Washington publishes the most Polyomavirus and related diseases research, followed by The University of Texas MD Anderson Cancer Center and University of Pennsylvania.
By volume, 2022–2025
- 1 University of WashingtonUnited States 22 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 20 works
- 3 University of PennsylvaniaUnited States 15 works
- 4 Cleveland ClinicUnited States 14 works
- 5 Washington University in St. LouisUnited States 13 works
- 6 Stanford UniversityUnited States 13 works
- 7 Harvard UniversityUnited States 12 works
- 8 Fred Hutch Cancer CenterUnited States 12 works
- 9 Northwestern UniversityUnited States 12 works
- 10 Massachusetts General HospitalUnited States 12 works
Who are the leading researchers in Polyomavirus and related diseases?
The most-cited researchers publishing on Polyomavirus and related diseases include Mohammad Ali Sahraian.
- 1 Mohammad Ali Sahraian Iran 4.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Polyomavirus and related diseases research done?
The largest centres of Polyomavirus and related diseases research in 2022–2025 are New York (United States), Tokyo (Japan), Philadelphia (United States) and Beijing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda, Seattle and Philadelphia.
Largest cities, 2022–2025
Where it is the local speciality
- BethesdaUS · 28.3 works7.4×
- SeattleUS · 40.3 works6.9×
- PhiladelphiaUS · 45.5 works5.6×
- ClevelandUS · 24.7 works5.6×
Location quotient: how much more of its research is in Polyomavirus and related diseases than the world average.
Where is the best place to study Polyomavirus and related diseases?
Among universities, judged by research, Medical University of Vienna, University of Washington and Washington University in St. Louis score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Medical University of ViennaAustria | 70.7 | 20.7% | 12.3× | 12 | -4.8% |
| 2 | University of WashingtonUnited States | 62.7 | 13.8% | 6.9× | 22 | +32.1% |
| 3 | Washington University in St. LouisUnited States | 57.5 | 19.9% | 6.1× | 13 | +28.1% |
| 4 | University of PennsylvaniaUnited States | 55.8 | 17.4% | 5.4× | 15 | +31.9% |
| 5 | Stanford UniversityUnited States | 55.7 | 18.9% | 3.5× | 13 | +70.6% |
| 6 | Harvard UniversityUnited States | 42.2 | 17.4% | 3.1× | 12 | -24.7% |
| 7 | Sun Yat-sen UniversityChina | 41.9 | 19.6% | 1.7× | 8 | +93.3% |
| 8 | Johns Hopkins UniversityUnited States | 41.1 | 19.9% | 3.4× | 11 | -32.5% |
| 9 | Northwestern UniversityUnited States | 35.3 | 11.2% | 5.7× | 12 | -29.1% |
| 10 | University of California, San FranciscoUnited States | 31.0 | 14.3% | 4.1× | 8 | -0.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Polyomavirus and related diseases research growing?
Output in 2018–2022 was 15% higher than in 2013–2017, peaking in 2020. The fastest-growing topics are Polyomavirus and related diseases.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.